Medical Dialogues » Alopecia Areata
4 FOLLOWERS
Get the latest news, and breaking news about Alopecia Areata. Stay connected to all updates on alopecia areata! Blog. At Medical Dialogues, we are a team of medical reporters strongly advocating transparency in the medical sector through the free flow of medical information health, and medical news.
Medical Dialogues » Alopecia Areata
3w ago
USA: A recent medical education article published in the Journal of the American Academy of Dermatology reviews the various clinical applications of ..read more
Medical Dialogues » Alopecia Areata
3M ago
South Korea: A nationwide study involving more than half a million South Koreans revealed a significant increase in the incidence of alopecia areata ..read more
Medical Dialogues » Alopecia Areata
4M ago
The agreement includes an upfront payment of USD 15 million, regulatory and commercial milestones, and royalties ..read more
Medical Dialogues » Alopecia Areata
5M ago
Alopecia areata is a condition where the immune system attacks hair follicles and causes hair to fall out, often in clumps ..read more
Medical Dialogues » Alopecia Areata
5M ago
SCD-153 is a first-in-class topical drug for the treatment of alopecia areata developed jointly by SPARC, JHU and IOCB ..read more
Medical Dialogues » Alopecia Areata
6M ago
China: New research has demonstrated the safety and effectiveness of oral tofacitinib as a treatment option for pediatric alopecia areata (AA ..read more
Medical Dialogues » Alopecia Areata
6M ago
USA: A pooled analysis of the BRAVE-AA1 and BRAVE-AA2 trials revealed that severe alopecia areata patients not achieving successful regrowth of scalp ..read more
Medical Dialogues » Alopecia Areata
6M ago
Mumbai: Sun Pharmaceutical Industries Ltd has announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application ..read more
Pfizer Litfulo gets European Commission approval for adolescents, adults with severe alopecia areata
Medical Dialogues » Alopecia Areata
7M ago
New York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for LITFULO (ritlecitinib) to treat ..read more
Medical Dialogues » Alopecia Areata
7M ago
The European Commission has authorized the marketing of ritlecitinib for treatment of severe alopecia areata for adolescents and adults ..read more